Safety and Efficacy Evaluation of Topical AL-60371 Otic Suspension, 0.3% in the Treatment of Acute Otitis Externa
NCT01535560
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
589
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Otitis Externa
Interventions
DRUG:
AL-60371, 0.3% otic suspension
DRUG:
AL-60371 Vehicle
Sponsor
Alcon Research